相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database
Ugo Giovanni Falagario et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
Modulation of complement activation by pentraxin-3 in prostate cancer
Giovanni Stallone et al.
SCIENTIFIC REPORTS (2020)
Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators
Ugo Giovanni Falagario et al.
EUROPEAN UROLOGY ONCOLOGY (2020)
The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort
Axel Moller et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2019)
Guidelines for Reporting of Statistics for Clinical Research in Urology
Melissa Assel et al.
JOURNAL OF UROLOGY (2019)
The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential
Peter Strom et al.
EUROPEAN UROLOGY (2018)
Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging
Henrik Gronberg et al.
EUROPEAN UROLOGY (2018)
Typing the atypical: Diagnostic issues and predictive markers in suspicious prostate lesions
Francesca Sanguedolce et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2017)
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Definition of Grading Patterns and Proposal for a New Grading System
Jonathan I. Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study
Richard J. Bryant et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naive Men
Claire de la Calle et al.
JOURNAL OF UROLOGY (2015)
Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study
Richard J. Bryant et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer
Giovanni Stallone et al.
CANCER RESEARCH (2014)
Prostate cancer detection rates in different biopsy schemes. Which cores for which patients?
Luigi Cormio et al.
WORLD JOURNAL OF UROLOGY (2014)
The Prostate Health Index: a new test for the detection of prostate cancer
Stacy Loeb et al.
THERAPEUTIC ADVANCES IN UROLOGY (2014)
Systematic Review of Complications of Prostate Biopsy
Stacy Loeb et al.
EUROPEAN UROLOGY (2013)
Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel
Luigi Cormio et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy
Luigi Cormio et al.
BJU INTERNATIONAL (2012)
Positive predictive value of prostate biopsy indicated by prostate-specific-antigen-based prostate cancer screening: trends over time in a European randomized trial
Leonard P. Bokhorst et al.
BJU INTERNATIONAL (2012)
Risk profiles of prostate cancers identified from UK primary care using national referral guidelines
H. Serag et al.
BRITISH JOURNAL OF CANCER (2012)
Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma
Marco Tafani et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Biomarkers of Systemic Inflammation and Risk of Incident, Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial
Jeannette M. Schenk et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication
Andrew Vickers et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cancer and the Complement Cascade
Martin J. Rutkowski et al.
MOLECULAR CANCER RESEARCH (2010)
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Goteborg, Sweden
Andrew J. Vickers et al.
BMC MEDICINE (2008)
The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial
J. Curtis Nickel et al.
EUROPEAN UROLOGY (2008)
The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells
Paramita Baruah et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans
G Peri et al.
CIRCULATION (2000)
分享论文
